Catalyst Funds Management’s BridgeBio Oncology BBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$125K Buy
+30,601
New +$238K 0.01% 552

Other funds holding BBOT

Catalyst Funds Management's BBOT Position: Q3 2026 in Review

Catalyst Funds Management opened a new position in BridgeBio Oncology (BBOT) in Q3 2026: 30,601 shares worth $125K. The stake represents 0.01% of the portfolio and ranks #552 among its holdings.

44 funds tracked by Wall St. Rank hold BBOT as of Q3 2026.

  • Catalyst Funds Management held 30,601 shares of BridgeBio Oncology worth $125K as of Q3 2026.
  • BridgeBio Oncology was a new Catalyst Funds Management position in Q3 2026.
  • BridgeBio Oncology made up 0.01% of Catalyst Funds Management's portfolio in Q3 2026, its #552 holding.
  • 44 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q3 2026.

Based on Catalyst Funds Management's 13F filing for Q3 2026, filed 12 Nov 2026.